Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

Anne Mette Fisker Hag; Rasmus Sejersten Ripa; Sune Folke Pedersen; Rasmus Poul Bodholdt; Andreas Kjaer

doi:10.1111/cpf.12017

Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

Anne Mette Fisker Hag, Rasmus Sejersten Ripa, Sune Folke Pedersen, Rasmus Poul Bodholdt, Andreas Kjaer

Endocrinology and Metabolism

2 Citations (Scopus)

Abstract

Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.

Original language	English
Journal	Clinical Physiology and Functional Imaging
Volume	33
Issue number	3
Pages (from-to)	173-85
Number of pages	13
ISSN	1475-0961
DOIs	https://doi.org/10.1111/cpf.12017
Publication status	Published - May 2013

Access to Document

10.1111/cpf.12017

Cite this

@article{4c54823a0b2b47539335f511a289b5cd,

title = "Small animal positron emission tomography imaging and in vivo studies of atherosclerosis",

abstract = "Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.",

author = "Hag, {Anne Mette Fisker} and Ripa, {Rasmus Sejersten} and Pedersen, {Sune Folke} and Bodholdt, {Rasmus Poul} and Andreas Kjaer",

note = "{\textcopyright} 2013 The Authors Clinical Physiology and Functional Imaging {\textcopyright} 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine.",

year = "2013",

month = may,

doi = "10.1111/cpf.12017",

language = "English",

volume = "33",

pages = "173--85",

journal = "Clinical Physiology and Functional Imaging",

issn = "1475-0961",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

AU - Hag, Anne Mette Fisker

AU - Ripa, Rasmus Sejersten

AU - Pedersen, Sune Folke

AU - Bodholdt, Rasmus Poul

AU - Kjaer, Andreas

PY - 2013/5

Y1 - 2013/5

N2 - Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.

AB - Atherosclerosis is a growing health challenge globally, and despite our knowledge of the disease has increased over the last couple of decades, many unanswered questions remain. As molecular imaging can be used to visualize, characterize and measure biological processes at the molecular and cellular levels in living systems, this technology represents an opportunity to investigate some of these questions in vivo. In addition, molecular imaging may be translated into clinical use and eventually pave the way for more personalized treatment regimes in patients. Here, we review the current knowledge obtained from in vivo positron emission tomography studies of atherosclerosis performed in small animals.

U2 - 10.1111/cpf.12017

DO - 10.1111/cpf.12017

M3 - Journal article

C2 - 23522010

SN - 1475-0961

VL - 33

SP - 173

EP - 185

JO - Clinical Physiology and Functional Imaging

JF - Clinical Physiology and Functional Imaging

IS - 3

ER -

Small animal positron emission tomography imaging and in vivo studies of atherosclerosis

Abstract

Access to Document

Fingerprint

Cite this